CMC Biologics Overview

  • Founded

  • 2001

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 303

Employees
  • Latest Deal Type

  • M&A

  • Latest Deal Amount

  • $594M

CMC Biologics General Information

Description

Manufacturer of active bio-pharmaceutical ingredients designed to provide faster and more effective answers to the bio-pharmaceutical industry's growing need for outsourced development and manufacturing resources. The company's bio-pharmaceutical ingredients caters to the need of clinical trials and commercial supplies, enabling bio-pharmaceutical industry to develop and commercialize drugs for treating patients.

Contact Information

Website
www.cmcbio.com
Formerly Known As
CMC Biopharmaceuticals
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
AGC (Tokyo)
Primary Office
  • Vandtaarnsvej 83B
  • Soeborg
  • 2860 Copenhagen
  • Denmark

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CMC Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Feb-2017 $594M 00000 00000 Completed Profitable
4. Later Stage VC 29-Feb-2008 00000 00000 Completed Profitable
3. Early Stage VC 05-Jan-2005 0000 0000 Completed Startup
2. Early Stage VC 01-Jan-2002 Completed Startup
1. Seed Round 01-Jan-2001 Completed Startup
To view CMC Biologics’s complete valuation and funding history, request access »

CMC Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of active bio-pharmaceutical ingredients designed to provide faster and more effective answers to the bio-p
Biotechnology
Copenhagen, Denmark
303 As of 2017
00000
0000 0000-00-00
000000&0 00000

000000

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
000000000000000
Loures, Portugal
0000 As of 0000

00000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000000
Basel, Switzerland
00000 As of 0000
00000
0.000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CMC Biologics Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hovione Corporation Loures, Portugal 0000
00000 00000 Corporation Basel, Switzerland 00000 00000 00000000000 00000
000000 Formerly PE-Backed San Diego, CA 00 000000&0
000 00000000000000 Corporation Latina Scalo, Italy 000
000 000000 0000000 Private Equity-Backed Oxford, United Kingdom 00 00000 000000000000 00000
You’re viewing 5 of 20 competitors. Get the full list »

CMC Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CMC Biologics Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BankInvest Biotech Ventures Venture Capital Minority 000 0000 000000 0
C.W. Obel PE/Buyout Minority 000 0000 000000 0
CatPen Other Minority 000 0000 000000 0
European Equity Partners Venture Capital Minority 000 0000 000000 0
IPSA( Asset Management) Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

CMC Biologics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 (0000000 31-Jul-2012 0000000000 Pharmaceuticals 00000 000
To view CMC Biologics’s complete acquisitions history, request access »

Ready to get started?

Request a free trial